Themis Bioscience GmbH

Themis – The Vaccine Innovation Boutique Themis Bioscience is a biotechnology company developing vaccines to prevent infectious diseases. The company’s development focus is primarily concentrated on emerging and specialist indications, advancing promising vaccines from preclinical to late-stage clinical development phases.

  • Mitarbeiterzahl

    5
  • Ausrichtungen
    • Therapie-Entwickler
  • Gegründet

    2009
  • Aktualisiert am

    30.05.2018